The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost and efficacy of low-dose pembrolizumab in the treatment of non-small cell lung cancer patients in Asia.
 
Jia Li Low
No Relationships to Disclose
 
Kenneth Sooi
No Relationships to Disclose
 
Yiqing Huang
No Relationships to Disclose
 
Gloria HJ Chan
No Relationships to Disclose
 
Yvonne Ang
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Wan Qin Chong
No Relationships to Disclose
 
Hon Lyn Tan
No Relationships to Disclose
 
Natalie Ngoi
Honoraria - Johnson & Johnson
Travel, Accommodations, Expenses - AstraZeneca
 
Joan Choo
No Relationships to Disclose
 
Matilda Lee
No Relationships to Disclose
 
Vaishnavi Muthu
No Relationships to Disclose
 
Yugarajah Asokumaran
No Relationships to Disclose
 
Robert John Walsh
Stock and Other Ownership Interests - Celgene; Merck
 
Rachel Su Jen Wong
No Relationships to Disclose
 
Zhi Yao Chan
No Relationships to Disclose
 
Ross A. Soo
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical; Takeda; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Raghav Sundar
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; Taiho Pharmaceutical
Research Funding - MSD; Paxman
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Roche; Taiho Pharmaceutical
 
Wei-Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Eisai; Lilly; Sanofi/Aventis; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Pfizer